Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2019 Oct;156(4):685-695.
doi: 10.1016/j.chest.2019.03.041. Epub 2019 May 15.

The St. George's Respiratory Questionnaire Definition of Chronic Bronchitis May Be a Better Predictor of COPD Exacerbations Compared With the Classic Definition

Collaborators, Affiliations
Comparative Study

The St. George's Respiratory Questionnaire Definition of Chronic Bronchitis May Be a Better Predictor of COPD Exacerbations Compared With the Classic Definition

Victor Kim et al. Chest. 2019 Oct.

Abstract

Background: Chronic bronchitis (CB) increases risk of COPD exacerbations. We have shown that the St. George's Respiratory Questionnaire (SGRQ) CB definition identifies patients with a similar clinical phenotype as classically defined CB. Whether the SGRQ CB definition is a predictor of future COPD exacerbations is unknown.

Methods: We analyzed 7,557 smokers with normal spirometry and Global Initiative for Chronic Obstructive Lung Disease stage 1-4 COPD in the Genetic Epidemiology of COPD study with longitudinal follow-up data on exacerbations. Subjects were divided into classic CB+ or classic CB-, using the classic definition. In addition, subjects were divided into SGRQ CB+ or SGRQ CB-. Exacerbation frequency and severe exacerbation frequency were determined in each group. Multivariable linear regressions were performed for exacerbation frequency with either classic CB or SGRQ CB and relevant covariates.

Results: There were 1,434 classic CB+ subjects and 2,290 SGRQ CB+ subjects. The classic CB+ group had a greater exacerbation frequency compared with the classic CB- group (0.69 ± 1.26 vs 0.36 ± 0.90 exacerbations per patient per year; P < .0001) and a greater severe exacerbation frequency (0.26 ± 0.74 vs 0.13 ± 0.46 severe exacerbations per patient per year; P < .0001). There were similar differences between the SGRQ CB+ and SGRQ CB- groups. In multivariable analysis, both SGRQ CB and classic CB were independent predictors of exacerbation frequency, but SGRQ CB had a higher regression coefficient. In addition, SGRQ CB was an independent predictor of severe exacerbation frequency whereas classic CB was not.

Conclusions: The SGRQ CB definition identified more subjects at risk for future exacerbations than the classic CB definition. SGRQ CB was at least a similar if not better predictor of future exacerbations than classic CB.

Trial registration: ClinicalTrials.gov NCT00608764.

Keywords: COPD; chronic bronchitis; cough; exacerbations.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Percent breakdown of each of the four chronic bronchitis groups. SGRQ = St. George’s Respiratory Questionnaire.
Figure 2
Figure 2
Differences in exacerbation frequency across GOLD stages. Red, classic CB+ vs classic CB; blue, SGRQ CB+ vs SGRQ CB. Circles represent mean difference and error bars represent 95% CI. *P < .05 and †P < .0001 compared with classic CB or SGRQ CB, respectively, on multivariable linear regression. CB = chronic bronchitis; GOLD = Global Initiative for Chronic Obstructive Lung Disease. See Figure 1 legend for expansion of other abbreviation.
Figure 3
Figure 3
Differences in severe exacerbation frequency across GOLD stages. Red, classic CB+ vs classic CB; blue, SGRQ CB+ vs SGRQ CB. Circles represent mean difference and error bars represent 95% CI. *P < .05 and †P < .0001 compared with classic CB or SGRQ CB, respectively, on multivariable linear regression. See Figure 1 and 2 legends for expansion of abbreviations.
Figure 4
Figure 4
OR for exacerbation frequency ≥ 2/y. See Figure 1 legend for expansion of abbreviation.
Figure 5
Figure 5
OR for severe exacerbation frequency ≥ 1/y. See Figure 1 legend for expansion of abbreviation.

Comment in

References

    1. US Burden of Disease Collaborators. Mokdad A.H., Ballestros K., Echko M. The state of US health, 1990-2016: burden of diseases, injuries, and risk factors among US states. JAMA. 2018;319(14):1444–1472. - PMC - PubMed
    1. Kim V., Criner G.J. The chronic bronchitis phenotype in chronic obstructive pulmonary disease: features and implications. Curr Opin Pulm Med. 2015;21(2):133–141. - PMC - PubMed
    1. Vestbo J., Prescott E., Lange P., Copenhagen City Heart Study Group Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Am J Respir Crit Care Med. 1996;153(5):1530–1535. - PubMed
    1. Pelkonen M., Notkola I.L., Nissinen A., Tukiainen H., Koskela H. Thirty-year cumulative incidence of chronic bronchitis and COPD in relation to 30-year pulmonary function and 40-year mortality: a follow-up in middle-aged rural men. Chest. 2006;130(4):1129–1137. - PubMed
    1. Guerra S., Sherrill D.L., Venker C., Ceccato C.M., Halonen M., Martinez F.D. Chronic bronchitis before age 50 years predicts incident airflow limitation and mortality risk. Thorax. 2009;64(10):894–900. - PMC - PubMed

Publication types

Associated data